Rose DiMarco, PharmD, BCPS, BCOP from Pharmacy Times - Journalist Profile

	Profile	Recent Articles on Subject
1	Rose DiMarco, PharmD, BCPS, BCOP Pharmacy Times Dedicated journal for oncology practitioners. Huntington, New York oncologyhealthcare	Key Points of Emphasis Surrounding CDK4/6 Inhibitor in mBC Treatment - 12 months ago Progression-Free Survival and Overall Survival Associated With CDK4/6 Inhibitor Therapy - about 1 year ago Hormone Therapy in Patients with HR+/HER2- Metastatic Breast Cancer - about 1 year ago
2	Ryan Haumschild, PharmD, MS, MBA Pharmacy Times Director of Pharmacy. Editorial Board member. Atlanta, Georgia pharmacyhealthcareeditorial workadvisory	Key Points of Emphasis Surrounding CDK4/6 Inhibitor in mBC Treatment - 12 months ago Progression-Free Survival and Overall Survival Associated With CDK4/6 Inhibitor Therapy - about 1 year ago Hormone Therapy in Patients with HR+/HER2- Metastatic Breast Cancer - about 1 year ago
3	Heather Moore, CPP, PharmD, BCOP Pharmacy Times Oncology Pharmacist. Exercise Enthusiast. Animal Lover. Durham, North Carolina PharmacyOncologyFitness	Key Points of Emphasis Surrounding CDK4/6 Inhibitor in mBC Treatment - 12 months ago Progression-Free Survival and Overall Survival Associated With CDK4/6 Inhibitor Therapy - about 1 year ago
4	Jacob K. Kettle, PharmD, BCOP Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Key Points of Emphasis Surrounding CDK4/6 Inhibitor in mBC Treatment - 12 months ago